This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 1984.
Company Filing History:
Years Active: 1984
Title: The Innovations of Stephen H. Larsen
Introduction
Stephen H. Larsen is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of antibiotics, holding a total of 2 patents. His work focuses on the development of novel antibiotic compounds and their production processes.
Latest Patents
Larsen's latest patents include the Antibiotic A53868 and the process for its production. The Antibiotic A53868 factor A is identified as N.sup.2 -glycyl-N-(2-methylene-2-phosphonoethyl)leucinamide. This compound, along with its salts, is useful as an antibiotic or as intermediates to antibiotics. The methods of preparing A53868 factor A involve fermentation of the microorganism Streptomyces luridus, specifically the strain S. luridus NRRL 15101.
Career Highlights
Stephen H. Larsen is currently associated with Eli Lilly and Company, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing antibiotic research and development.
Collaborations
Larsen has collaborated with notable colleagues, including Ronald D. Johnson and Ralph M. Kastner, contributing to a dynamic research environment that fosters innovation.
Conclusion
Stephen H. Larsen's contributions to antibiotic development and his innovative patents highlight his significant role in the pharmaceutical industry. His work continues to impact the field positively.